Psychological Interventions for Psychosis: A Meta-Analysis of Comparative Outcome Studies
Publication: American Journal of Psychiatry
Abstract
Objective
Meta-analyses have demonstrated the efficacy of various interventions for psychosis, and a small number of studies have compared such interventions. The aim of this study was to provide further insight into the relative efficacy of psychological interventions for psychosis.
Method
Forty-eight outcome trials comparing psychological interventions for psychosis were identified. The comparisons included 3,295 participants. Categorization of interventions resulted in six interventions being compared against other interventions pooled. Hedges’ g was calculated for all comparisons. Risk of bias was assessed using four items of the Cochrane risk of bias tool, and sensitivity analyses were conducted. Researcher allegiance was assessed, and sensitivity analyses were conducted for robust significant findings.
Results
Cognitive-behavioral therapy (CBT) was significantly more efficacious than other interventions pooled in reducing positive symptoms (g=0.16). This finding was robust in all sensitivity analyses for risk of bias but lost significance in sensitivity analyses for researcher allegiance, which suffered from low power. Social skills training was significantly more efficacious in reducing negative symptoms (g=0.27). This finding was robust in sensitivity analyses for risk of bias and researcher allegiance. Significant findings for CBT, social skills training, and cognitive remediation for overall symptoms were not robust after sensitivity analyses. CBT was significantly more efficacious when compared directly with befriending for overall symptoms (g=0.42) and supportive counseling for positive symptoms (g=0.23).
Conclusions
There are small but reliable differences in efficacy between psychological interventions for psychosis, and they occur in a pattern consistent with the specific factors of particular interventions.
It has been suggested that all psychotherapies are roughly equivalent in efficacy (1–6), although some meta-analyses have suggested differences in relative efficacy between treatments (7). Previous meta-analyses have demonstrated the absolute efficacy of some psychological interventions for psychosis (8–16), while others have been suggested to be unreliable (17). Comparatively little is understood about the relative efficacy of psychological treatments for psychosis. The most extensive meta-analytic evidence was provided by the U.K. National Institute for Clinical Excellence (NICE) (18). However, risk of bias was not assessed, and many comparisons of psychological interventions against other active treatments were underpowered, including subgroup comparisons for positive and negative symptoms (19).
Other comparative meta-analyses have not consistently demonstrated superiority of the intervention of interest. Jones et al. (20) compared cognitive-behavioral therapy (CBT) against other interventions pooled and concluded that CBT was not reliably more efficacious. A limitation of that analysis was that the CBT group also included compliance studies (21). Lynch et al. (22) compared CBT to active control conditions and found a statistically significant benefit (Hedges’ g=0.2) of CBT compared with active controls pooled for positive symptoms. However, the authors concluded that CBT was no better than nonspecific comparison treatments and that the significant effect size could be explained by lack of blinding. There were some methodological criticisms of the Lynch et al. study (23–25), and there remains controversy over which psychological interventions are most efficacious for psychosis.
No meta-analysis since NICE (18) has compiled all randomized controlled trials in which two psychological interventions for psychosis are compared and pooled these as comparison conditions (2). Given the limitations of the NICE meta-analyses and of many new studies that have been published since, a further comparative meta-analysis is warranted. Whereas previous meta-analyses tended to examine only CBT compared with active treatments, in this analysis we considered all intervention types for which sufficient numbers of studies have been conducted. Our aim is to improve our understanding of which therapy is most efficacious, and for which particular symptoms.
Method
Search Strategy
A systematic literature search conducted in May 2013 identified 5,910 articles for potential inclusion. Four databases were included in the search: PubMed (1,539 abstracts), Embase (1,016 abstracts), PsycInfo (2,128 abstracts), and the Cochrane Central Register of Controlled Trials (1,227 abstracts). Abstracts were identified by entering terms indicative of common psychological interventions for psychosis combined with search terms intended to identify all relevant psychotic disorders. MeSH terms, exploded terms, and text words were employed. Reference lists of published meta-analyses were also examined.
Study Selection
We included randomized trials that included a comparison of at least two psychological interventions intended to be therapeutic and to improve psychiatric symptoms in psychosis; included outcome measures intended to assess psychotic or psychiatric symptoms; and included primarily participants with diagnoses of psychotic disorders. Trials that included patients with mood disorders with psychotic features were included only when such patients were in a minority within the sample.
Trials were excluded if the comparison condition could not be deemed an active psychological intervention (e.g., attention controls, treatment as usual, waiting list); if participants were prodromal or ultra-high risk; or if the interventions were primarily aimed at medication adherence or compliance. Only articles in English or German were considered. Interventions were defined as described in Table 1. Two authors (D.T. and M.v.d.G.) categorized interventions into relevant comparisons, and disagreements were resolved by discussion.
| Treatment | Definition | Nst | Np |
|---|---|---|---|
| Befriending | Participants are assigned social support to match therapy hours provided in other conditions. Typically this consists of friendly discussion or social activities, not directly related to symptoms, with a supportive and empathic individual. Discussion instead focuses primarily on neutral topics, such as current affairs or hobbies, and structured group activities may also be provided. Befriending has been suggested as an efficacious intervention in reducing symptoms of psychosis (26, 27). | 11 | 400 |
| Cognitive-behavioral therapy (CBT) | CBT aims to promote awareness of the links between thoughts, behaviors, and feelings to help implement changes in symptoms and functioning. Therapists focus on the modification of dysfunctional thoughts and self-defeating behaviors that perpetuate symptoms or suffering. CBT specifically targeting psychosis has been developed primarily since the 1990s and was originally focused on coping with symptoms (28, 29), whereas more recent approaches have focused on challenging maladaptive cognitions through cognitive restructuring and a formulation-based approach (30–32). We identified these as two main subtypes of CBT for the purposes of this meta-analysis, referring to them as “coping enhancement” and “generic CBT.” | 22 | 706 |
| Cognitive remediation | Cognitive deficits have been widely implicated as influential in the development and course of psychosis and have therefore been suggested as worthy treatment targets (33). Cognitive remediation refers to those interventions that target basic cognitive processes, such as working memory, attention, and executive function. This intervention is intended to improve these basic cognitive functions and may also be intended to improve various other aspects of functioning. Computer-based tasks are often the chosen method of implementing cognitive remediation. | 11 | 475 |
| Psychoeducation | Provision of relevant information to participants about their diagnosis with the aim of improving their understanding of and coping with their diagnosis. Various psychoeducation methods have been developed for psychosis that go further than provision of basic information and therefore may involve development of coping strategies and role playing. A group format is often utilized, and there is often considerable diversity in what may be labeled “psychoeducation.” This modality is often used as a comparator intervention for more standardized forms of intervention. | 8 | 249 |
| Social skills training | Behavioral intervention based on behavioral and social learning traditions in which participants’ social functioning is targeted in order to improve their ability to perform in social situations, manage daily life tasks, and reduce social distress. Importance is typically placed on verbal and nonverbal communication alongside learning appropriate perception and responses to social cues. The intervention may also include training in independent living skills. | 16 | 541 |
| Supportive counseling | Nondirective talking therapy that may be based on the work of Carl Rogers (34) or may simply be described in studies as a nondirective intervention in which participants have an open forum to discuss their difficulties, without being actively led or challenged by the therapist. Supportive counseling was therefore defined as an intervention in which the common factors of psychotherapy were present without the specific techniques applied in other, more directive therapies, such as CBT. The opportunity to discuss problems with an empathic therapist in a healing setting may provide relief for the participant without any focus on acquiring new skills or challenging cognitive distortions. Supportive counseling is often used as a means of comparing other interventions against only the common factors of psychological interventions (1). | 17 | 529 |
a
Nst=number of studies; Np=number of participants who received the intervention.
Quality Assessment
To assess the methodological quality of the studies included, we used the first four criteria of the Cochrane Collaboration risk of bias tool—sequence generation, allocation concealment, blinding of assessors, and incomplete outcome data (there is no clear indication that the fifth [selective outcome reporting] and sixth [other sources of bias] items influence validity [19]). Because it is impossible for these studies to employ a double-blind design, the third item (blinding of assessors) was adapted to include only outcome assessors in masking procedures. Two authors (D.T. and E.K.) assessed the risk of bias, and disagreements were resolved by discussion.
Data Extraction and Selection of Outcome Measures
Data were extracted by one of the authors (D.T.) and checked for consistency by another (E.K.). A spreadsheet piloted in a previous meta-analysis was used for data collection. Attempts were made to contact authors in cases of missing or unusable data, and calculations of missing values were carried out in accordance with the Cochrane Handbook (35).
Table 2 summarizes the study characteristics. Statistical data were extracted for outcome measures relevant to psychotic or psychiatric symptoms. In studies where multiple relevant outcome measures were used, data from all outcome measures were collected and combined as a mean effect size. Dichotomous outcome data were also considered in cases where symptom measures had been converted to dichotomous outcomes, such as clinical exacerbations.
| Study Authors (Reference Number) | Sample Characteristics | Relevant Comparisons | Symptom Outcome Measures | Format | Bias Risk (0–4) | Duration (weeks) | Follow-Up | Allegiance |
|---|---|---|---|---|---|---|---|---|
| Barretto et al. (36) | DSM-IV schizophrenia; 6 months clozapine treatment-resistant; outpatients | CBT (N=12) vs. BF (N=10) | CGI, BPRS, PANSS | Individual | 2 | 21 | 6 months | CBT |
| Bechdolf et al. (37, 38) | ICD-10 schizophrenia or related disorder; inpatients | CBT (N=40) vs. PE (N=48) | PANSS | Group | 0 | 8 | 6 and 24 months | None |
| Bowie et al. (39) | Schizophrenia or schizoaffective disorder; outpatients | SST (N=38) vs. CR (N=38) | PANSS | Group | 1 | 12 | 24 weeks | None |
| Cather et al. (40) | Schizophrenia or schizoaffective disorder; outpatients | CBT (N=15) vs. PE (N=13) | PANSS, PSYRATS | Individual | 1 | 16 | N/A | CBT |
| Crawford et al. (41) | Schizophrenia; outpatients | BF (N=140) vs. AT (N=140) | PANSS | Group | 0 | 12 | 24 months | AT |
| Dobson et al. (42) | DSM-III schizophrenia; outpatients (severe patients excluded) | SST (N=15) vs. BF (N=13) | PANSS | Group | 3 | 11 | 3 months | None |
| Drury et al. (43, 44) | Current functional psychosis, excluding bipolar, hypomania, organic syndrome, confusional states, and drug or alcohol disorders | CBT (N=20) vs. BF (N=20) | PAS | Both | 3 | 12 | 5 years | CBT |
| Durham et al. (45) | Schizophrenia, schizoaffective disorder, or delusional disorder with positive symptoms; outpatient and inpatient | CBT (N=22) vs. SC (N=23) | PANSS, PSYRATS, GAS | Individual | 0 | 39 | 3 months | CBT |
| Eack et al. (46) | DSM-IV schizophrenia or schizoaffective disorder, in early stages of illness; outpatients | CR (N=31) vs. PE (N=27) | Composite symptoms | Group | 2 | 104 | 12 months | CR |
| Falloon et al. (47, 48) | DSM-III schizophrenia from families high in expressed emotion; inpatients | SC (N=18) vs. FI (N=18) | Clinical exacerbation; remission; target symptom ratings | Individual | 3 | 39 | 24 months | FI |
| Farreny et al. (49) | DSM-IV-TR schizophrenia or schizoaffective disorder; illness duration >2 years; outpatients | CR (N=34) vs. BF (N=28) | PANSS | Group | 2 | 16 | 40 weeks | CR |
| Fries et al. (50) | ICD-10 schizophrenia and schizoaffective disorder; at least two hospitalizations; in at least partial remission at baseline | PE (N=23) vs. SC (N=17) | BPRS, SANS | Group | 4 | 25 | 12 months | None |
| Garety et al. (51) | Recently relapsed nonaffective psychosis (ICD-10 F2 or DSM-IV), with positive symptoms; carers included in study | CBT (N=27) vs. FI (N=28) | PANSS, PSYRATS, BDI, BAI | Individual | 0 | 52 | 24 months | None |
| Haddock et al. (52) | DSM-IV schizophrenia or schizoaffective disorder (< 5 years); current acute ward admission for positive symptoms | CBT (N=9) vs. SC (N=10) | BPRS | Individual | 1 | 5 | N/A | CBT |
| Haddock et al. (53) | DSM-IV schizophrenia or schizoaffective disorder; with history of violence; current antipsychotic medication and positive symptoms | CBT (N=38) vs. BF (N=39) | PANSS, PSYRATS | Individual | 0 | 26 | 12 months | CBT |
| Hayes et al. (54) | DSM-III-R schizophrenia; noncurrent positive symptoms; from a range of services | SST (N=23) vs. SC (N=22) | BPRS, SANS | Group | 4 | 18 | 6 months | SST |
| Hogarty et al. (55, 56) | RDC schizophrenia or schizoaffective disorder from families high in expressed emotion; inpatients | SST (N=23) vs. FI (N=23) | Symptom relapse | Individual | 4 | 104 | N/A | None |
| Hogarty et al. (57, 58) | DSM-III-R or DSM-IV schizophrenia or schizoaffective disorder; outpatients | CR (N=67) vs. PE (N=54) | Composite symptoms | Group | 3 | 52 | 24 months | CR |
| Horan et al. (59) | DSM-IV schizophrenia or schizoaffective disorder; clinically stable outpatients | SST (N=17) vs. PE (N=17) | BPRS | Group | 2 | 6 | N/A | SST |
| Horan et al. (60) | DSM-IV schizophrenia, schizoaffective disorder, delusional disorder, or psychosis not otherwise specified (not secondary to substance disorder); clinically stable outpatients | SST (N=19) vs. CR (N=24) | BPRS | Group | 2 | 12 | N/A | SST |
| Jackson et al. (61) | First-episode psychosis, including schizophrenia, schizophreniform, schizoaffective, bipolar, delusional disorder, and psychosis not otherwise specified; inpatient and outpatient | CBT (N=31) vs. BF (N=31) | BPRS, SANS | Individual | 2 | 12 | 12 months | CBT |
| Keefe et al. (62) | Chronic DSM-IV schizophrenia, moderate severity | CR (N=27) vs. BF (N=26) | PANSS | Group | 1 | 12 | N/A | CR |
| Klingberg et al. (63, 64) | DSM-IV schizophrenia, with at least one negative symptom; positive symptoms excluded; outpatients | CBT (N=99) vs. CR (N=99) | PANSS, SANS, CDSS, CGI, SCL-90 | Individual | 0 | 52 | N/A | CBT |
| Lecomte et al. (65, 66) | Early psychosis (< 2 years), with current psychotic symptoms; stabilized outpatients | CBT (N=48) vs. SST (N=54) | BPRS | Group | 0 | 13 | 6 and 12 months | None |
| Lewis et al. (30) | DSM-IV schizophrenia, schizophreniform, schizoaffective, or delusional disorder; first or second admission; inpatients and outpatients | CBT (N=101) vs. SC (N=106) | PANSS, PSYRATS | Individual | 0 | 5 | 18 months | CBT |
| Liberman et al. (67) | Persistent and unremitting schizophrenia; outpatients | SST (N=42) vs. OT (N=42) | BSI, GAS, BPRS | Both | 3 | 26 | 24 months | None |
| Lukoff et al. (68) | DSM-III schizophrenia; inpatients | SST (N=14) vs. PE (N=14) | PAS | Group | 2 | 10 | N/A | None |
| Marder et al. (69) | DSM-III schizophrenia; at least two acute episodes or 2 years of psychotic symptoms; male outpatients | SST (N=13) vs. SC (N=14) | BPRS exacerbations | Group | 3 | 104 | N/A | None |
| Moritz et al. (70) | Broad psychotic inpatients who met criteria for schizophreniform disorder | CBT (N=24) vs. CR (N=24) | PANSS, PSYRATS | Both | 0 | 4 | N/A | CBT |
| Ng and Cheung (71) | DSM-IV schizophrenia; inpatients | SST (N=18) vs. SC (N=18) | BPRS, SANS | Group | 0 | 8 | 6 months | SST |
| O’Connor et al. (72) | DSM-IV delusional disorder; stabilized on medication | CBT (N=12) vs. SC (N=12) | MADS, BAI, BDI | Individual | 3 | 24 | N/A | CBT |
| Ojeda et al. (73) | DSM-IV schizophrenia; treatment-resistant; inpatients | CR (N=47) vs. OT (N=46) | PANSS | Individual | 2 | 13 | N/A | CR |
| Patterson et al. (74) | DSM-IV schizophrenia or schizophreniform disorder; older chronic Latino inpatients | SST (N=21) vs. SC (N=8) | PANSS | Group | 3 | 26 | 12 months | SST |
| Patterson et al. (75) | DSM-IV schizophrenia or schizophreniform disorder; older chronic inpatients | SST (N=124) vs. SC (N=116) | PANSS, HAM-D | Group | 2 | 26 | N/A | SST |
| Penadés et al. (76, 77) | DSM-IV schizophrenia, chronic, with a prevalence of negative symptoms and cognitive impairment | CBT (N=20) vs. CR (N=20) | PANSS | Individual | 0 | 17 | 6 months | CR |
| Penn et al. (78) | Schizophrenia or schizoaffective disorder and current auditory hallucinations; outpatients | CBT (N=32) vs. SC (N=33) | PANSS, BAVQ, PSYRATS | Group | 0 | 12 | 3 and 12 months | CBT |
| Pinto et al. (79) | DSM-IV schizophrenia; treatment-refractory; outpatients | CBT (N=19) vs. SC (N=18) | BPRS, SAPS, SANS | Individual | 3 | 26 | N/A | CBT |
| Rodewald et al. (80) | DSM schizophrenia or schizoaffective disorder; inpatients | CR (N=44) vs. PST (N=45) | PANSS | Group | 3 | 3 | N/A | PST |
| Röhricht and Priebe (81) | DSM-IV schizophrenia; at least two episodes; outpatients | SC (N=21) vs. BP (N=24) | PANSS | Group | 0 | 10 | 4 months | BP |
| Sensky et al. (26) and Turkington et al. (82) | DSM-IV or ICD-10 schizophrenia; treatment-resistant; outpatients | CBT (N=46) vs. BF (N=44) | CPRS, SANS, MADRS | Individual | 0 | 39 | 9 months, 5 years | CBT |
| Shawyer et al. (83) | DSM-IV schizophrenia or related condition; with command hallucinations in previous 6 months; outpatients | CBT (N=21) vs. BF (N=22) | PANSS, PSYRATS, CH | Individual | 0 | 15 | 6 months | CBT |
| Tarrier et al. (28) | DSM-III-R schizophrenia; treatment resistant | CBT (N=15) vs. PST (N=12) | BPRS, PSE | Individual | 3 | 6 | 6 months | CBT |
| Tarrier et al. (29, 84, 85, 86) | Schizophrenia according to PSE; acute-ward inpatients | CBT (N=19) vs. SC (N=19) | BPRS, SANS | Individual | 0 | 13 | 12 months | CBT |
| Tas et al. (87) | DSM-IV schizophrenia; clinically stable outpatients | SST (N=22) vs. BF (N=27) | PANSS | Group | 0 | 16 | N/A | SST |
| Valmaggia et al. (31) | DSM-IV schizophrenia; with residual delusions or auditory hallucinations; medication resistant | CBT (N=36) vs. SC (N=26) | PANSS, PSYRATS | Individual | 0 | 22 | 6 months | CBT |
| Wykes et al. (88, 89) | DSM-IV schizophrenia; with >2 years contact with services; outpatients and inpatients | CR (N=20) vs. OT (N=16) | BPRS | Individual | 0 | 13 | 6 months | CR |
| Xiang et al. (90) | DSM-IV schizophrenia; clinically stable outpatients | SST (N=48) vs. SC (N=48) | PANSS | Group | 1 | 9 | 6 months | SST |
| Xiang et al. (91) | DSM-IV schizophrenia; clinically stable inpatients and outpatients | SST (N=50) vs. PE (N=53) | PANSS | Group | 2 | 4 | 6 and 12 months | SST |
a
AT=art therapy; BAI=Beck Anxiety Inventory; BAVQ=Beliefs About Voices Questionnaire; BDI=Beck Depression Inventory; BF=befriending; BPRS=Brief Psychiatric Rating Scale; BSI=Brief Symptom Inventory; BP=body psychotherapy; CBT=cognitive-behavioral therapy; CDSS=Calgary Depression Scale for Schizophrenia; CGI=Clinical Global Impressions scale; CH=command hallucinations; CPRS=Comprehensive Psychopathological Rating Scale; CR=cognitive remediation; FI=family intervention; GAS=Global Assessment Scale; HAM-D=Hamilton Depression Rating Scale; MADRS=Montgomery-Åsberg Depression Rating Scale; MADS=Maudsley Assessment of Delusions Schedule; N=number of participants in treatment group; OT=occupational therapy; PANSS=Positive and Negative Syndrome Scale; PAS=Psychiatric Assessment Scale; PE=psychoeducation; PSE=Present State Examination; PSYRATS=Psychotic Symptom Rating Scale; PST=problem-solving therapy; RDC=Research Diagnostic Criteria; SANS=Scale for the Assessment of Negative Symptoms; SAPS=Scale for the Assessment of Positive Symptoms; SC=supportive counseling; SCL-90=Symptom Checklist–90; SST=social skills training.
Meta-Analyses
Psychological interventions for psychosis qualified for inclusion in a separate meta-analysis when there were at least five eligible randomized controlled trials comparing that intervention to another psychological intervention. The comparison group for each separate meta-analysis therefore became the pooled set of comparison interventions from these studies (e.g., CBT compared with other interventions pooled). This resulted in meta-analyses for six intervention types. Separate sub-meta-analyses for positive, negative, or general symptoms were undertaken when there were sufficient studies (≥5) assessing these outcomes.
The Comprehensive Meta-Analysis software package, version 2.2.021, was used for all analyses and calculations. For each individual meta-analysis, aggregated effect sizes indicating the pooled difference between the two groups were calculated at end of treatment using Hedges' g. Hedges' g provides a better effect estimate for small sample sizes than similar measures applied to continuous outcome variables, such as Cohen’s d (92). Alpha was set at 0.05, and 95% confidence intervals were computed.
Heterogeneity
A chi-square test provided a Q statistic to determine the presence of heterogeneity alongside an I2 statistic as a description of the percentage of the variance in each meta-analysis that could be explained by heterogeneity between the studies rather than by chance. A value of 0% indicates no heterogeneity, 25% low heterogeneity, 50% moderate heterogeneity, and 75% high heterogeneity (93).
Additional Analyses
Publication bias was assessed for primary outcomes in each of the six meta-analyses by examining funnel plots produced by the Comprehensive Meta-Analysis program (94) as well as by using the trim-and-fill procedure to estimate the effect size after accounting for publication bias (95). Egger’s test of the intercept was conducted to quantify the bias shown by the funnel plots and to determine whether it was significant.
Direct comparisons were made between psychological interventions when there were at least five studies available comparing two specific treatments. Subgroup analyses were conducted for the intervention with the highest number of eligible studies, namely, CBT. This included splitting CBT into two relevant subtypes to determine whether they had similar efficacy. Differential effects of group or individual format were investigated by entering intervention format as a moderator variable.
Researcher allegiance was examined for all studies, using a tool adapted from a previous meta-analysis (96) (see the data supplement that accompanies the online edition of this article). Two researchers independently rated studies and discussed agreement. Subgroup analyses for researcher allegiance were conducted on robust significant findings that survived the sensitivity analyses for high risk of bias, although this was not possible for all such findings because of the limited number of studies available.
Power Calculation
It was expected that a limited number of studies would be available for certain comparisons. Based on the recommendations of Borenstein (97), power calculations were conducted to determine how many studies were required for sufficient statistical power to identify relevant effects. Previous meta-analyses identified small effect sizes (g=0.1 or g=0.2) in favor of specific interventions. Conservatively assuming a high level of between-study variance (tau-squared), a statistical power of 0.80, and an alpha of 0.05, we estimated that 22 studies with a mean of 30 participants in each intervention arm would be required to detect an effect size of g=0.2. To detect an effect size of g=0.1, we estimated that 88 studies would be required.
Results
After removal of duplicates, 4,768 titles and abstracts were examined, of which 489 articles were retrieved for possible inclusion. Figure 1 describes the selection process. In the 48 included studies, a total of 3,295 participants were included in relevant comparisons of psychological interventions. Six common psychological intervention modalities were identified.
Twenty-four studies used the group format, 21 used the individual format, and three used a combination of individual and group sessions. CBT had the highest proportion of studies using only the individual format (77%), followed by supportive counseling (47%), befriending (45%), cognitive remediation (36%), psychoeducation (12.5%), and social skills training (6%). The time from baseline to posttreatment assessment ranged from 3 weeks to 104 weeks. Risk of bias varied among studies (0–4) and among intervention types. CBT had the highest proportion of studies assessed as having no bias risk (59%), followed by befriending (45.5%), supportive counseling (41%), cognitive remediation (36%), social skills training (12.5%), and psychoeducation (12.5%).
Differences Between Psychological Interventions and Other Interventions Pooled
The results of the six meta-analyses comparing psychological interventions with other interventions pooled are presented in Table 3. Separate meta-analyses were conducted for psychosis symptom groupings. Within each symptom grouping, sensitivity analyses were conducted for varying levels of bias risk. Sensitivity analyses were conducted only when at least four studies were available for that comparison.
| Comparison | N | Hedges’ g | 95% CI | Z-Score | Q | I2 (%) |
|---|---|---|---|---|---|---|
| Befriending vs. all other therapies | ||||||
| All symptoms | ||||||
| All eligible studies | 11 | –0.37* | –0.60, –0.13 | –3.08 | 21.24* | 52.93 |
| Excluding high risk of bias (≥3) | 9 | –0.28* | –0.51, –0.05 | –2.39 | 14.84 | 46.08 |
| Excluding low risk of bias (≥2) | 6 | –0.22 | –0.50, 0.06 | –1.56 | 10.78 | 53.61 |
| Excluding any risk of bias (≥1) | 5 | –0.20 | –0.52, 0.11 | –1.27 | 10.04* | 60.17 |
| Positive symptoms | ||||||
| All eligible studies/excluding high risk (≥3) | 6 | –0.14 | –0.41, 0.13 | –0.10 | 8.81 | 43.23 |
| Excluding any risk of bias (≥1) | 4 | –0.17 | –0.56, 0.22 | –0.86 | 8.50* | 64.72 |
| Negative symptoms | ||||||
| All eligible studies | 9 | –0.22 | –0.41, 0.04 | –1.69 | 18.12* | 55.85 |
| Excluding high risk of bias (≥3) | 8 | –0.18 | –0.45, 0.80 | –1.37 | 15.93* | 56.67 |
| Excluding low (≥2) and any risk of bias (≥1) | 5 | –0.10 | –0.44, 0.24 | –0.56 | 11.94* | 66.49 |
| General symptoms (PANSS) | 5 | –0.24 | –0.61, 0.13 | –1.26 | 10.42* | 61.61 |
| Cognitive behavioral therapy vs. all other therapies | ||||||
| All symptoms | ||||||
| All eligible studies | 22 | 0.16* | 0.04, 0.28 | 2.64 | 23.91 | 12.18 |
| Excluding high risk of bias (≥3) | 18 | 0.12* | 0.00, 0.23 | 2.01 | 14.98 | 0.00 |
| Excluding low risk of bias (≥2) | 15 | 0.10 | –0.03, 0.22 | 1.53 | 11.30 | 0.00 |
| Excluding any risk of bias (≥1) | 13 | 0.11 | –0.02, 0.24 | 1.72 | 9.16 | 0.00 |
| Positive symptoms | ||||||
| All eligible studies | 17 | 0.16* | 0.04, 0.28 | 2.67 | 11.17 | 0.00 |
| Excluding high risk of bias (≥3) | 15 | 0.14* | 0.02, 0.27 | 2.32 | 9.42 | 0.00 |
| Excluding low risk of bias (≥2) | 12 | 0.15* | 0.02, 0.28 | 2.18 | 9.19 | 0.00 |
| Excluding any risk of bias (≥1) | 11 | 0.14* | 0.00, 0.27 | 1.97 | 7.44 | 0.00 |
| Negative symptoms | ||||||
| All eligible studies | 15 | 0.04 | –0.09, 0.16 | 0.55 | 13.94 | 0.00 |
| Excluding high risk of bias (≥3) | 14 | 0.02 | –0.10, 0.15 | 0.36 | 13.04 | 0.34 |
| Excluding low risk of bias (≥2) | 11 | –0.00 | –0.15, 0.14 | –0.06 | 8.13 | 0.00 |
| Excluding any risk of bias (≥1) | 10 | –0.01 | –0.15, 0.14 | –0.06 | 8.14 | 0.00 |
| General symptoms (PANSS) | ||||||
| All eligible studies/low risk of bias (≥2) | 8 | 0.10 | –0.13, 0.32 | 0.86 | 12.10 | 42.16 |
| Excluding any risk of bias (≥1) | 7 | 0.05 | –0.14, 0.24 | 0.54 | 7.60 | 21.06 |
| Cognitive remediation vs. all other therapies | ||||||
| All symptoms | ||||||
| All eligible studies | 11 | 0.13 | –0.05, 0.31 | 1.46 | 14.63 | 31.69 |
| Excluding high risk of bias (≥3) | 10 | 0.20* | 0.01, 0.39 | 2.06 | 11.34 | 20.65 |
| Excluding low risk of bias (≥2) | 6 | 0.14 | –0.05, 0.33 | 1.41 | 3.21 | 0.00 |
| Excluding any risk of bias (≥1) | 4 | 0.12 | –0.11, 0.34 | 1.02 | 2.49 | 0.00 |
| Positive symptoms | ||||||
| All eligible studies | 6 | 0.16 | –0.17, 0.49 | 0.97 | 14.11* | 64.56 |
| Excluding low risk of bias (≥2) | 4 | 0.29 | –0.06, 0.64 | 1.63 | 6.61 | 54.59 |
| Negative symptoms | ||||||
| All eligible studies | 6 | –0.14 | –0.39, 0.06 | –1.12 | 8.47 | 40.99 |
| Excluding high (≥3) and low (≥2) risk of bias | 4 | –0.08 | –0.38, 0.22 | –0.50 | 5.23 | 42.59 |
| Psychoeducation vs. all other therapies | ||||||
| All symptoms | ||||||
| All eligible studies | 8 | 0.10 | –0.27, 0.11 | –0.80 | 8.02 | 12.66 |
| Excluding high risk of bias (≥3) | 6 | –0.13 | –0.41, 0.14 | 0.94 | 7.43 | 32.67 |
| Positive symptoms | ||||||
| All eligible studies/excluding high risk (≥3) | 4 | 0.19 | –0.06, 0.44 | 1.50 | 1.70 | 0.00 |
| Negative symptoms | ||||||
| All eligible studies | 5 | 0.02 | –0.22, 0.25 | 0.13 | 3.06 | 0.00 |
| Excluding high risk of bias (≥3) | 4 | 0.03 | –0.22, 0.28 | 0.23 | 2.97 | 0.00 |
| Social skills training vs. all other therapies | ||||||
| All symptoms | ||||||
| All eligible studies | 16 | 0.06 | –0.17, 0.28 | 0.49 | 45.33* | 66.91 |
| Excluding high risk of bias (≥3) | 10 | 0.19* | 0.02, 0.36 | 2.15 | 8.72 | 0.00 |
| Excluding low risk of bias (≥2) | 4 | 0.34 | –0.02, 0.70 | 1.87 | 5.47 | 45.13 |
| Positive symptoms | ||||||
| All eligible studies | 7 | 0.09 | –0.23, 0.41 | 0.56 | 16.44* | 63.51 |
| Excluding high risk of bias (≥3) | 6 | 0.09 | –0.26, 0.45 | 0.50 | 16.41* | 69.53 |
| Negative symptoms | ||||||
| All eligible studies | 9 | 0.27* | 0.01, 0.53 | 2.01 | 17.33* | 53.83 |
| Excluding high risk of bias (≥3) | 7 | 0.32* | 0.07, 0.56 | 2.55 | 10.25 | 41.47 |
| Excluding low risk of bias (≥2) | 4 | 0.56* | 0.31, 0.82 | 4.29 | 1.99 | 0.00 |
| Supportive counseling vs. all other therapies | ||||||
| All symptoms | ||||||
| All eligible studies | 17 | 0.00 | –0.21, 0.22 | 0.04 | 40.31* | 60.31 |
| Excluding high risk of bias (≥3) | 10 | 0.01 | –0.30, 0.32 | 0.06 | 32.97 | 72.70 |
| Excluding low risk of bias (≥2) | 9 | –0.12 | –0.30, 0.05 | –1.37 | 6.18 | 0.00 |
| Excluding any risk of bias (≥1) | 7 | –0.08 | –0.28, 0.11 | –0.83 | 1.74 | 0.00 |
| Positive symptoms | ||||||
| All eligible studies | 8 | –0.14 | –0.36, 0.09 | –1.12 | 10.28 | 31.90 |
| Excluding high (≥3) and low (≥2) risk of bias | 6 | –0.05 | –0.25, 0.15 | –0.51 | 5.33 | 6.27 |
| Excluding any risk of bias (≥1) | 5 | –0.02 | –0.27, 0.23 | –0.17 | 5.00 | 19.98 |
| Negative symptoms | ||||||
| All eligible studies | 9 | –0.12 | –0.41, 0.17 | –0.83 | 18.55* | 56.87 |
| Excluding high (≥3) and low (≥2) risk of bias | 6 | –0.21 | –0.57, 0.15 | –1.13 | 13.34* | 62.52 |
| Excluding any risk of bias (≥1) | 5 | –0.09 | –0.45, 0.27 | –0.50 | 7.74 | 48.30 |
a
All comparisons were made using a random-effects model. Risk-of-bias analyses were included only in instances where at least four studies were available. N=number of comparisons; PANSS=Positive and Negative Syndrome Scale.
* p<0.05.
Befriending was less efficacious for all symptom outcome measures pooled compared with other therapies pooled (g=−0.366, p<0.05). This effect was robust when studies with a high risk of bias were excluded (g=−0.279, p<0.05) but lost significance when studies with a low risk and no risk of bias were excluded. Removing the studies with a low risk and no risk of bias also limited the power of this comparison. Seven comparisons of befriending and other interventions pooled showed moderate heterogeneity, and two comparisons showed low heterogeneity.
CBT was more efficacious compared with other interventions pooled for all symptom outcome measures pooled (g=0.161, p<0.05). This effect was robust when studies with a high risk of bias were excluded (g=0.118, p<0.05) but lost significance when studies with a low risk and no risk of bias were excluded. For positive symptom outcome measures, CBT was more efficacious (g=0.162, p<0.05). This effect was robust in all three sensitivity analyses when we sequentially removed studies with a high risk (g=0.144, p<0.05), a low risk (g=0.149, p<0.05), and no risk of bias (g=0.137, p<0.05). All comparisons of CBT with other interventions pooled showed no heterogeneity or low heterogeneity.
Social skills training was more efficacious compared with other interventions pooled for negative symptoms (g=0.267, p<0.05). This finding was robust when studies with a high risk of bias (g=0.317, p<0.05) and those with a low risk of bias (g=0.563, p<0.05) were excluded. Only one social skills training study suggested no risk of bias, so it was not possible to run a sensitivity analysis for no risk of bias. Social skills training was more efficacious for all symptom measures pooled when studies with a high risk of bias were excluded (g=0.187, p<0.05), but this comparison lost significance when all studies were included or when studies with a low risk of bias were excluded. Here too, not enough studies were available for a comparison including only studies with no risk of bias. Heterogeneity among comparisons of social skills training and other interventions pooled varied, with four comparisons showing moderate heterogeneity.
Cognitive remediation was more efficacious than other interventions pooled for all symptoms in the sensitivity analysis excluding high risk of bias (g=0.202, p<0.05) but was not shown as significantly more efficacious in any other comparisons. Heterogeneity varied among comparisons for cognitive remediation, with two comparisons showing moderate heterogeneity.
Direct Comparisons of Psychological Interventions
The results of direct comparisons between interventions are presented in Table 4. Limited comparisons were possible since few studies were available. CBT was more efficacious than befriending for all symptom measures pooled (g=0.419, p<0.05). CBT was also more efficacious than supportive counseling for positive symptoms (g=0.226, p<0.05).
| Comparison | N | Hedges’ g | 95% CI | Z-Score | Q | I2 (%) | p |
|---|---|---|---|---|---|---|---|
| Direct comparisons of two interventions | |||||||
| CBT vs. befriending | |||||||
| All symptoms (R) | 6 | 0.42* | 0.15, 0.69 | 3.02 | 7.00 | 28.61 | |
| CBT vs. supportive counseling | |||||||
| All symptoms (F/R) | 8 | 0.10 | –0.10, 0.30 | 0.99 | 6.09 | 0.00 | |
| Positive symptoms (F/R) | 6 | 0.23* | 0.01, 0.44 | 2.07 | 5.00 | 0.04 | |
| Social skills training vs. supportive counseling | |||||||
| All symptoms (R) | 6 | –0.07 | –0.54, 0.40 | –0.29 | 26.27 | 80.96 | |
| CBT subtypes vs. other interventions pooled | |||||||
| Coping enhancement subtype | |||||||
| All symptoms (F/R) | 6 | –0.01 | –0.19, 0.18 | –0.08 | 1.83 | 0.00 | |
| Negative symptoms (F/R) | 5 | –0.04 | –0.23, 0.15 | –0.41 | 2.45 | 0.00 | |
| Generic subtype | |||||||
| All symptoms (R) | 16 | 0.22* | 0.08, 0.37 | 2.97 | 16.96 | 11.58 | |
| Positive symptoms (F/R) | 13 | 0.17* | 0.03, 0.32 | 2.28 | 10.66 | 0.00 | |
| Negative symptoms (R) | 10 | 0.01 | –0.08, 0.28 | 1.07 | 10.44 | 13.76 | |
| Subgroup analyses of CBT: group vs. individual formatb | |||||||
| All symptoms | |||||||
| Individual (R) | 18 | 0.18* | 0.05, 0.32 | 2.66 | 19.93 | 14.9 | |
| Group (R) | 3 | 0.00 | –0.26, 0.27 | 0.03 | 1.08 | 0.00 | |
| Overall (R) | 21 | 0.13 | –0.02, 0.29 | 1.64 | 22.45 | 10.93 | 0.24 |
| Positive symptoms | |||||||
| Individual (F/R) | 13 | 0.16* | 0.02, 0.30 | 2.17 | 9.04 | 0.00 | |
| Group (F/R) | 3 | 0.12 | –0.13, 0.36 | 0.93 | 0.39 | 0.00 | |
| Overall (F/R) | 16 | 0.15* | 0.01, 0.34 | 2.04 | 9.50 | 0.00 | 0.80 |
| Negative symptoms | |||||||
| Individual (F/R) | 12 | 0.09 | –0.06, 0.23 | 1.15 | 12.05 | 8.68 | |
| Group (F/R) | 3 | –0.11 | –0.35, 0.14 | –0.85 | 0.16 | 0.00 | |
| Overall (F/R) | 15 | 0.02 | –0.17, 0.20 | 0.17 | 13.94 | 0.00 | 0.19 |
| Subgroup analyses of researcher allegiance for comparisons with robust significant effects | |||||||
| CBT vs. all other therapiesc | |||||||
| Positive symptoms (F/M) | |||||||
| Excluding high risk of bias (≥3) | |||||||
| No allegiance | 3 | 0.10 | –0.15, 0.35 | 0.80 | 0.24 | 0.00 | 0.42 |
| Allegiance for CBT | 11 | 0.17 | 0.01, 0.32 | 2.40 | 5.35 | 0.00 | |
| Excluding low risk of bias (≥2) | |||||||
| No allegiance | 2 | 0.08 | –0.25, 0.40 | 0.50 | 0.21 | 0.00 | 0.60 |
| Allegiance for CBT | 9 | 0.18 | 0.03, 0.33 | 2.33 | 5.07 | 0.00 | |
| Excluding any risk of bias (≥1) | |||||||
| No allegiance | 2 | 0.08 | –0.25, 0.40 | 0.50 | 0.21 | 0.00 | 0.58 |
| Allegiance for CBT | 8 | 0.19 | 0.03, 0.34 | 2.36 | 4.96 | 0.00 | |
| Social skills training vs. all other therapies | |||||||
| Negative symptoms (M) | |||||||
| All eligible studies | |||||||
| No allegiance | 3 | 0.37 | 0.04, 0.7 | 2.20 | 2.30 | 13.27 | 0.55 |
| Allegiance for social skills training | 6 | 0.21 | –0.21, 0.62 | 0.98 | 15.50 | 67.7 | |
| Excluding high risk of bias (≥3) | |||||||
| No allegiance | 2 | 0.30 | –0.10, 0.71 | 1.48 | 1.51 | 33.82 | 0.83 |
| Allegiance for social skills training | 6 | 0.36 | 0.04, 0.69 | 2.19 | 8.97 | 44.25 | |
a
The p values in the right-hand column refer to the difference between subgroup effect sizes. CBT=cognitive-behavioral therapy; R=random-effects model; M=mixed-effects model; F/M=mixed model and fixed model identical; F/R=fixed and random-effects model identical; N=number of comparisons.
b
Excluding one study that used both group and individual format.
c
Excluding one study with allegiance against CBT.
Meta-Analyses for CBT Subtypes
To examine whether there were differences between CBT subtypes (coping enhancement and generic CBT), subgroup analyses were conducted. Results included in Table 4 suggest that generic CBT was more efficacious for all symptom measures pooled and for positive symptoms. The between-group comparisons for group versus individual format were not significant, but this comparison was hampered by low power. No subgroup analyses showed significant heterogeneity.
Researcher allegiance.
Sensitivity analyses for researcher allegiance were conducted for the robust effects of CBT on positive symptoms and social skills training on negative symptoms. The effect of CBT on positive symptoms became nonsignificant in both sensitivity analyses, although only three studies could be included in the no-allegiance group, resulting in low power. The effect of social skills training on negative symptoms remained significant in the sensitivity analyses, although comparison was not possible for the stricter risk of bias categories because of the limited number of studies available.
Publication bias.
Funnel plots and the trim-and-fill procedure suggested the presence of publication bias in some comparisons of the cognitive remediation and social skills training meta-analyses. The funnel plot for all symptoms pooled in the cognitive remediation meta-analysis suggested that three studies with negative findings remained unpublished. Using the trim-and-fill procedure to investigate the significant effect shown for overall symptoms without studies with a high risk of bias (g=0.20), two studies were trimmed, meaning the effect size was reduced to g=0.10 (95% CI=−0.12, 0.32). For the social skills training overall symptoms meta-analyses, the funnel plot suggested that seven studies had not been published when all studies were included. However, when the funnel plot and trim-and-fill procedure were examined for the only significant finding within this meta-analysis, there was no suggestion of publication bias. Similarly, there was no suggestion of publication bias for the significant effects of social skills training found for negative symptoms.
Discussion
This series of meta-analyses comparing psychological interventions for psychosis found significant differences in their relative efficacy for the reduction of psychotic symptoms, as summarized in Figure 2. While some of these differences lost significance when sensitivity analyses were conducted for risk of bias, others were more robust. CBT showed a small but robust superiority in reducing positive symptoms, while social skills training showed a small but relatively robust superiority in reducing negative symptoms. Befriending was shown as less efficacious than other interventions in reducing overall symptoms, although this result was not robust when the more stringent sensitivity analyses for risk of bias were conducted. Similarly, significant effects suggesting benefits of CBT, social skills training, and cognitive remediation for all symptom measures pooled were not significant after sensitivity analyses for risk of bias. It should be noted that the more robust sensitivity analyses resulted in the statistical power dropping well below 0.80. Heterogeneity did not appear as a significant problem in the CBT meta-analyses, whereas some comparisons for the other intervention modalities did show moderate to high heterogeneity, including social skills training. Sensitivity analyses for researcher allegiance resulted in the effect of CBT on positive symptoms losing significance. This was not the case for the effect of social skills training on negative symptoms. Researcher allegiance comparisons were hampered by very low power; it should also be noted that no significant differences in effect sizes were found when comparing studies for CBT and social skills training with allegiance against those with no allegiance.
FIGURE 2. Main Results of Comparisons of Psychological Interventions for Psychotic Symptomsa
CBT also showed superiority when compared directly to befriending for all symptoms and when compared with supportive counseling for positive symptoms. The generic CBT subtype appeared more efficacious in reducing overall symptoms and positive symptoms.
With respect to the much discussed thesis that all psychotherapies produce similar outcomes (1), our results provide evidence that could both support and contradict this proposition. The differences shown between interventions are small in terms of clinical significance. This may suggest that the major therapeutic effects of interventions occur through common factors. However, the pattern of differences in efficacy is consistent with the specific aims of the interventions. CBT appears most successful in reducing positive symptoms, consistent with the rationale of challenging positive symptoms through a formulation-based approach and cognitive restructuring (31, 98). Similarly, social skills training appeared most suitable for reducing negative symptoms (54, 99). These findings provide potential evidence for the role of specific factors as at least partially influential in determining treatment outcome. When we consider that the effects of common factors are already accounted for in the treatment comparisons and that a high proportion of the participants also receive pharmacotherapy, findings suggesting that specific factors influence their targeted symptoms are of interest. The design of this study, however, does not allow us to control completely for other potential influences on outcome, which may explain the effect we are attributing to specific factors. An attempt was made to control for researcher allegiance, but only limited comparisons were possible, primarily because few studies showed no allegiance.
We are aware that CBT is uniform in its assumption that negative emotions and behavioral problems are the result of the appraisal and interpretation of antecedent events. By changing appraisal and interpretation of events and stimuli, the emotions and the behavior will change. However, there are variants within CBT that differ in degree of emphasis on cognitions or on behavioral experiments. We have the impression that variations in CBT are not typically reflected in results, although the meta-analysis by Wykes et al. (11) found a trend for larger effect sizes in more behavioral CBT. Comparisons could be made to antipsychotic medication, where almost all agents target dopamine D2 receptors. Although the compounds are slightly different from each other, they have about the same efficacy (100). A recent development is that CBT using the same general technique is becoming more focused. For example, CBT protocols are being developed to address command hallucinations (101) and negative symptoms (102, 103). Preliminary results show larger effect sizes for more focused applications compared with generic CBT for psychosis.
Our study had several limitations that affect the extent to which robust conclusions can be drawn from the results. The majority of comparisons had low statistical power (<0.80). Without satisfactory power, there is a high risk of type II errors. A limitation of any meta-analysis categorizing randomized controlled trials into groups by intervention type is that such decisions involve a degree of subjectivity. We attempted to address this issue by having two researchers agree on categorization. There was some controversy regarding study selection following the Lynch et al. CBT meta-analysis (22–24, 99). The risk of bias procedure applied in our meta-analysis addresses the issues raised about inclusion since all but one of the studies excluded in the Lynch et al. meta-analysis were excluded in the most stringent sensitivity analysis. For the aims of this meta-analysis, there did not appear to be any reason to exclude this study (75).
Another limitation concerns our focus on positive, negative, and general symptoms. While CBT, supportive counseling, and befriending target symptom reduction, psychoeducation, social skills training, and cognitive remediation only indirectly target symptoms. Psychoeducation is often intended to improve medication adherence, with secondary symptom improvement, and although the effects on symptoms were not significantly different from all other interventions, this does not mean that psychoeducation was not able to improve adherence. Similarly, cognitive remediation targets the improvement of cognitive functioning, and the absence of an effect on symptoms does not mean that there was no improvement in cognitive functioning. Those effects are beyond the scope of the meta-analyses we present and are not reported. It was also beyond the scope of this study to consider the possibility of patients with better prognosis being channeled into a particular treatment, interaction with pharmacotherapies, and diagnostic heterogeneity among samples, since information on these domains was not reliably available across studies.
There was considerable variety in the quality of studies as assessed by the risk of bias procedure, and there were marked differences in quality between specific intervention types. CBT had the highest proportion of studies assessed as having no risk of bias, and social skills training had the lowest. It is important that future studies on the relative efficacy of social skills training address these issues. Research should continue to compare psychological interventions for psychosis in order to improve statistical power in meta-analyses. It is essential, too, that comparative randomized controlled trials minimize bias risk and that the issue of researcher allegiance be addressed. Meta-analytic studies must also answer related questions about psychosis interventions, such as predictors of treatment outcome and dropout. This includes individual participant data meta-analyses, in which the authors of this study are currently involved. Future research may also focus on dismantling studies, which provide insight into the influence of common and specific factors. Future development of treatment plans may take into account the effects of specific factors on the specific symptom areas and integrate these to optimize both positive and negative symptom reduction.
In conclusion, although the differences observed between interventions for psychosis were small in this meta-analysis, the relatively robust nature of the differences and the pattern by which differences occur have implications for the continued clinical implementation, design, and improvement of psychosocial therapies for psychosis.
Acknowledgments
The authors thank Spyridon Kolovos, Hanna Wersebe, and Filip Smit for assistance in various parts of this project.
Supplementary Material
Supplementary Material (523_ds001.pdf)
- View/Download
- 32.12 KB
References
1.
Wampold BE: The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ, Routledge, 2001
2.
Cuijpers P, van Straten A, Andersson G, van Oppen P: Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008; 76:909–922
3.
Barth J, Munder T, Gerger H, Nüesch E, Trelle S, Znoj H, Jüni P, Cuijpers P: Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med 2013; 10:e1001454
4.
Baardseth TP, Goldberg SB, Pace BT, Wislocki AP, Frost ND, Siddiqui JR, Lindemann AM, Kivlighan DM, Laska KM, Del Re AC, Minami T, Wampold BE: Cognitive-behavioral therapy versus other therapies: redux. Clin Psychol Rev 2013; 33:395–405
5.
Miller S, Wampold B, Varhely K: Direct comparisons of treatment modalities for youth disorders: a meta-analysis. Psychother Res 2008; 18:5–14
6.
Benish SG, Imel ZE, Wampold BE: The relative efficacy of bona fide psychotherapies for treating post-traumatic stress disorder: a meta-analysis of direct comparisons. Clin Psychol Rev 2008; 28:746–758
7.
Siev J, Chambless DL: Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders. J Consult Clin Psychol 2007; 75:513–522
8.
Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C: Psychological treatments in schizophrenia, I: meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002; 32:763–782
9.
Pfammatter M, Junghan UM, Brenner HD: Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr Bull 2006; 32(suppl 1):S64–S80
10.
Zimmermann G, Favrod J, Trieu VH, Pomini V: The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res 2005; 77:1–9
11.
Wykes T, Steel C, Everitt B, Tarrier N: Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34:523–537
12.
Kurtz MM, Mueser KT: A meta-analysis of controlled research on social skills training for schizophrenia. J Consult Clin Psychol 2008; 76:491–504
13.
Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P: A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168:472–485
14.
Pharoah F, Mari J, Rathbone J, Wong W: Family intervention for schizophrenia. Cochrane Database Syst Rev 2010; 12:CD000088
15.
Pitschel-Walz G, Leucht S, Bäuml J, Kissling W, Engel RR: The effect of family interventions on relapse and rehospitalization in schizophrenia: a meta-analysis. Schizophr Bull 2001; 27:73–92
16.
Xia J, Merinder LB, Belgamwar MR: Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2011; 6:CD002831
17.
Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Martindale B, Orbach G, Morgan C: Psychological treatments in schizophrenia, II: meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychol Med 2002; 32:783–791
18.
National Institute of Clinical Excellence: Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. London, National Institute of Clinical Excellence, March 2009
19.
Higgins JPT, Altman DG (eds): Assessing risk of bias in included studies, in Cochrane Handbook for Systematic Reviews of Interventions. Edited by, Higgins JPT, Green S. Chichester, UK, Wiley-Blackwell, 2008, chap 8
20.
Jones C, Hacker D, Cormac I, Meaden A, Irving CB: Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012; 4:CD008712
21.
Kemp R, Hayward P, Applewhaite G, Everitt B, David A: Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996; 312:345–349
22.
Lynch D, Laws KR, McKenna PJ: Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med 2010; 40:9–24
23.
Kingdon D: Over-simplification and exclusion of non-conforming studies can demonstrate absence of effect: a lynching party? Psychol Med 2010; 40:25–27
24.
Lincoln TM: Letter to the editor: a comment on Lynch et al (2009). Psychol Med 2010; 40:877–880
25.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8:336–341
26.
Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O’Carroll MO, Barnes TRE: A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000; 57:165–172
27.
Milne D, Wharton S, James I, Turkington D: Befriending versus CBT for schizophrenia: a convergent and divergent fidelity check. Behav Cogn Psychother 2006; 34:25–30
28.
Tarrier N, Beckett R, Harwood S, Baker A, Yusupoff L, Ugarteburu I: A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients, I: outcome. Br J Psychiatry 1993; 162:524–532
29.
Tarrier N, Yusupoff L, Kinney C, McCarthy E, Gledhill A, Haddock G, Morris J: Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ 1998; 317:303–307
30.
Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, Benn A, Grazebrook K, Haley C, Akhtar S, Davies L, Palmer S, Faragher B, Dunn G: Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry Suppl 2002; 43:s91–s97
31.
Valmaggia LR, van der Gaag M, Tarrier N, Pijnenborg M, Slooff CJ: Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication: randomised controlled trial. Br J Psychiatry 2005; 186:324–330
32.
Kingdon DG, Turkington D: Cognitive Therapy of Schizophrenia (Guides to Individualized Evidence-Based Treatment). New York, Guilford Press, 2008
33.
Gold JM: Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 2004; 72:21–28
34.
Rogers CR: Client-Centered Therapy: Its Current Practice, Implications, and Theory. Boston, Houghton Mifflin, 1951
35.
Higgins J, Deeks JJ (eds): Selecting studies and collecting data, in Cochrane Handbook for Systematic Reviews of Interventions. Edited by, Higgins JPT, Green S. Chichester, UK, Wiley-Blackwell, 2008, chap 7
36.
Barretto EM, Kayo M, Avrichir BS, Sa AR, Camargo Md, Napolitano IC, Nery FG, Pinto JA, Bannwart S, Scemes S, Di Sarno E, Elkis H: A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia. J Nerv Ment Dis 2009; 197:865–868
37.
Bechdolf A, Knost B, Kuntermann C, Schiller S, Klosterkötter J, Hambrecht M, Pukrop R: A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr Scand 2004; 110:21–28
38.
Bechdolf A, Köhn D, Knost B, Pukrop R, Klosterkötter J: A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatr Scand 2005; 112:173–179
39.
Bowie CR, McGurk SR, Mausbach B, Patterson TL, Harvey PD: Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry 2012; 169:710–718
40.
Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC: A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophr Res 2005; 74:201–209
41.
Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O’Neill FA, Osborn DP, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team: Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. BMJ 2012; 344:e846
42.
Dobson DJ, McDougall G, Busheikin J, Aldous J: Effects of social skills training and social milieu treatment on symptoms of schizophrenia. Psychiatr Serv 1995; 46:376–380
43.
Drury V, Birchwood M, Cochrane R, Macmillan F: Cognitive therapy and recovery from acute psychosis: a controlled trial, I: impact on psychotic symptoms. Br J Psychiatry 1996; 169:593–601
44.
Drury V, Birchwood M, Cochrane R: Cognitive therapy and recovery from acute psychosis: a controlled trial, 3: five-year follow-up. Br J Psychiatry 2000; 177:8–14
45.
Durham RC, Guthrie M, Morton RV, Reid DA, Treliving LR, Fowler D, Macdonald RR: Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms: results to 3-month follow-up. Br J Psychiatry 2003; 182:303–311
46.
Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS: Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv 2009; 60:1468–1476
47.
Falloon IR, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM: Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med 1982; 306:1437–1440
48.
Falloon IR, Boyd JL, McGill CW, Williamson M, Razani J, Moss HB, Gilderman AM, Simpson GM: Family management in the prevention of morbidity of schizophrenia: clinical outcome of a two-year longitudinal study. Arch Gen Psychiatry 1985; 42:887–896
49.
Farreny A, Aguado J, Ochoa S, Huerta-Ramos E, Marsà F, López-Carrilero R, Carral V, Haro JM, Usall J: REPYFLEC cognitive remediation group training in schizophrenia: looking for an integrative approach. Schizophr Res 2012; 142:137–144
50.
Fries A, Pfammatter M, Andres A, Brenner HD: Wirksamkeit und Prozessmerkmale einer psychoedukativen und bewältigungsorientierten Gruppentherapie für schizophren und schizoaffektiv Erkrankte. Verhaltenstherapie 2004; 13:237–243
51.
Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E: Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br J Psychiatry 2008; 192:412–423
52.
Haddock G, Tarrier N, Morrison AP, Hopkins R, Drake R, Lewis S: A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis. Soc Psychiatry Psychiatr Epidemiol 1999; 34:254–258
53.
Haddock G, Barrowclough C, Shaw JJ, Dunn G, Novaco RW, Tarrier N: Cognitive-behavioural therapy v social activity therapy for people with psychosis and a history of violence: randomised controlled trial. Br J Psychiatry 2009; 194:152–157
54.
Hayes RL, Halford WK, Varghese FT: Social skills training with chronic schizophrenic patients: effects on negative symptoms and community functioning. Behav Ther 1995; 26:433–449
55.
Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Javna CD, Madonia MJ: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, I: one-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 1986; 43:633–642
56.
Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RF, Carter M; Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry 1991; 48:340–347
57.
Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R: Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 2004; 61:866–876
58.
Hogarty GE, Greenwald DP, Eack SM: Durability and mechanism of effects of cognitive enhancement therapy. Psychiatr Serv 2006; 57:1751–1757
59.
Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF: Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res 2009; 107:47–54
60.
Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, Marder SR, Green MF: Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res 2011; 45:1113–1122
61.
Jackson HJ, McGorry PD, Killackey E, Bendall S, Allott K, Dudgeon P, Gleeson J, Johnson T, Harrigan S: Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus befriending for first-episode psychosis: the ACE project. Psychol Med 2008; 38:725–735
62.
Keefe RS, Vinogradov S, Medalia A, Buckley PF, Caroff SN, D’Souza DC, Harvey PD, Graham KA, Hamer RM, Marder SM, Miller DD, Olson SJ, Patel JK, Velligan D, Walker TM, Haim AJ, Stroup TS: Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. J Clin Psychiatry 2012; 73:1016–1022
63.
Klingberg S, Wölwer W, Engel C, Wittorf A, Herrlich J, Meisner C, Buchkremer G, Wiedemann G: Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr Bull 2011; 37(suppl 2):S98–S110
64.
Klingberg S, Herrlich J, Wiedemann G, Wölwer W, Meisner C, Engel C, Jakobi-Malterre UE, Buchkremer G, Wittorf A: Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the Treatment of Negative Symptoms Study. J Nerv Ment Dis 2012; 200:569–576
65.
Lecomte T, Leclerc C, Corbière M, Wykes T, Wallace CJ, Spidel A: Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. J Nerv Ment Dis 2008; 196:866–875
66.
Lecomte T, Leclerc C, Wykes T: Group CBT for early psychosis: are there still benefits one year later? Int J Group Psychother 2012; 62:309–321
67.
Liberman RP, Wallace CJ, Blackwell G, Kopelowicz A, Vaccaro JV, Mintz J: Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. Am J Psychiatry 1998; 155:1087–1091
68.
Lukoff D, Wallace CJ, Liberman RP, Burke K: A holistic program for chronic schizophrenic patients. Schizophr Bull 1986; 12:274–282
69.
Marder SR, Wirshing WC, Mintz J, McKenzie J, Johnston K, Eckman TA, Lebell M, Zimmerman K, Liberman RP: Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. Am J Psychiatry 1996; 153:1585–1592
70.
Moritz S, Veckenstedt R, Randjbar S, Vitzthum F, Woodward TS: Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol Med 2011; 41:1823–1832
71.
Ng RMK, Cheung MSL: Social skills training in Hong Kong Chinese patients with chronic schizophrenia. Hong Kong J Psychiatry 2006; 16:14–20
72.
O’Connor K, Stip E, Pélissier MC, Aardema F, Guay S, Gaudette G, Van Haaster I, Robillard S, Grenier S, Careau Y, Doucet P, Leblanc V: Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. Can J Psychiatry 2007; 52:182–190
73.
Ojeda N, Peña J, Sánchez P, Bengoetxea E, Elizagárate E, Ezcurra J, Gutiérrez Fraile M: Efficiency of cognitive rehabilitation with REHACOP in chronic treatment resistant Hispanic patients. NeuroRehabilitation 2012; 30:65–74
74.
Patterson TL, Bucardo J, McKibbin CL, Mausbach BT, Moore D, Barrio C, Goldman SR, Jeste DV: Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophr Bull 2005; 31:922–930
75.
Patterson TL, Mausbach BT, McKibbin C, Goldman S, Bucardo J, Jeste DV: Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophr Res 2006; 86:291–299
76.
Penadés R, Catalán R, Salamero M, Boget T, Puig O, Guarch J, Gastó C: Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophr Res 2006; 87:323–331
77.
Penadés R, Catalán R, Puig O, Masana G, Pujol N, Navarro V, Guarch J, Gastó C: Executive function needs to be targeted to improve social functioning with cognitive remediation therapy (CRT) in schizophrenia. Psychiatry Res 2010; 177:41–45
78.
Penn DL, Meyer PS, Evans E, Wirth RJ, Cai K, Burchinal M: A randomized controlled trial of group cognitive-behavioral therapy vs enhanced supportive therapy for auditory hallucinations. Schizophr Res 2009; 109:52–59
79.
Pinto A, La Pia S, Mennella R, Giorgio D, DeSimone L: Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia. Psychiatr Serv 1999; 50:901–904
80.
Rodewald K, Rentrop M, Holt DV, Roesch-Ely D, Backenstrass M, Funke J, Weisbrod M, Kaiser S: Planning and problem-solving training for patients with schizophrenia: a randomized controlled trial. BMC Psychiatry 2011; 11:73
81.
Röhricht F, Priebe S: Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial. Psychol Med 2006; 36:669–678
82.
Turkington D, Sensky T, Scott J, Barnes TR, Nur U, Siddle R, Hammond K, Samarasekara N, Kingdon D: A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophr Res 2008; 98:1–7
83.
Shawyer F, Farhall J, Mackinnon A, Trauer T, Sims E, Ratcliff K, Larner C, Thomas N, Castle D, Mullen P, Copolov D: A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders. Behav Res Ther 2012; 50:110–121
84.
Tarrier N, Wittkowski A, Kinney C, McCarthy E, Morris J, Humphreys L: Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up. Br J Psychiatry 1999; 174:500–504
85.
Tarrier N, Kinney C, McCarthy E, Humphreys L, Wittkowski A, Morris J: Two-year follow-up of cognitive-behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. J Consult Clin Psychol 2000; 68:917–922
86.
Tarrier N, Kinney C, McCarthy E, Wittkowski A, Yusupoff L, Gledhill A: Are some types of psychotic symptoms more responsive to cognitive-behaviour therapy? Behav Cogn Psychother 2001; 29:45–55
87.
Tas C, Danaci AE, Cubukcuoglu Z, Brüne M: Impact of family involvement on social cognition training in clinically stable outpatients with schizophrenia: a randomized pilot study. Psychiatry Res 2012; 195:32–38
88.
Wykes T, Reeder C, Corner J, Williams C, Everitt B: The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull 1999; 25:291–307
89.
Wykes T, Reeder C, Williams C, Corner J, Rice C, Everitt B: Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophr Res 2003; 61:163–174
90.
Xiang Y, Weng Y, Li W, Gao L, Chen G, Xie L, Chang Y, Tang WK, Ungvari GS: Training patients with schizophrenia with the community re-entry module: a controlled study. Soc Psychiatry Psychiatr Epidemiol 2006; 41:464–469
91.
Xiang YT, Weng YZ, Li WY, Gao L, Chen GL, Xie L, Chang YL, Tang WK, Ungvari GS: Efficacy of the community re-entry module for patients with schizophrenia in Beijing, China: outcome at 2-year follow-up. Br J Psychiatry 2007; 190:49–56
92.
Deeks JJ, Higgins JPT, Altman DG (eds): Analysing data and undertaking meta-analyses, in Cochrane Handbook for Systematic Reviews of Interventions. Edited by, Higgins JPT, Green S. Chichester, UK, Wiley-Blackwell, 2008, chap 9
93.
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327:557–560
94.
Sterne AC, Egger M, Moher D (eds): Addressing reporting biases, in Cochrane Handbook for Systematic Reviews of Interventions. Edited by, Higgins JPT, Green S. Chichester, UK, Wiley-Blackwell, 2008, chap 10
95.
Duval S, Tweedie R: Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56:455–463
96.
Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G: The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 2012; 32:280–291
97.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR: Introduction to Meta-Analysis. Chichester, UK, Wiley, 2009
98.
Chadwick P, Birchwood M: The omnipotence of voices: a cognitive approach to auditory hallucinations. Br J Psychiatry 1994; 164:190–201
99.
Bellack AS, Agresta J, Gingerich S, Mueser KT: Social Skills Training for Schizophrenia: A Step-by-Step Guide, 2nd revised ed. New York, Guilford, 2004
100.
Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, Asenjo Lobos C, Schwarz S, Davis JM: A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2009; 166:152–163
101.
Trower P, Birchwood M, Meaden A, Byrne S, Nelson A, Ross K: Cognitive therapy for command hallucinations: randomised controlled trial. Br J Psychiatry 2004; 184:312–320
102.
Staring AB, Ter Huurne MA, van der Gaag M: Cognitive behavioral therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. J Behav Ther Exp Psychiatry 2013; 44:300–306
103.
Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT: Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch Gen Psychiatry 2012; 69:121–127
Information & Authors
Information
Published In
History
Received: 30 August 2013
Revision received: 21 November 2013
Accepted: 19 December 2013
Published online: 1 May 2014
Published in print: May 2014
Authors
Funding Information
The authors report no financial relationships with commercial interests.
Supplementary Material
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).